Multiple Voices on Authorship and Authority in Biomedical Publications
Main Article Content
Abstract
The intersection of industry sponsorship, government regulation, academic interests, and medical journals is a core interest in biomedical research, and one that overlaps with concerns in the rhetoric of health and medicine (RHM). At stake in conversations about this intersection are authority and participation: who is and is not invited to offer opinions and, even when invited, whose opinions are taken seriously. Following, colleagues with ties to the International Society of Medical Publication Professionals (ISMPP) present their ideas in response to questions about authorship and authority posed by another, who is also an RHM scholar. The answers of medical journal editors and publications professionals employed by corporate entities largely align with the view that both authorship and authority should be determined by scientific practice and knowledge rather than power relations or politics. A philosopher who gave an invited plenary talk at the national ISMPP meeting and participated in the organization’s first white paper offers a different perspective, considering the ways that fields self-constitute in part by bounding authority and authorship.
Article Details
References
Battisti, Wendy P., Wager, Elizabeth, Baltzer, Lise, et al. (2015) Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Annals of Internal Medicine,163:461-464; doi:10.7326/M15-0288
DeTora Lisa. (2017). “What is safety? Miracles, benefit-risk assessments, and the “Right to Try” International Journal of Clinical Practice, 71(7). doi: 10.1111/ijcp.12966.
Foucault, Michel. (1969). “What is an Author?” Available at: https://www.open.edu/openlearn/ocw/pluginfile.php/624849/mod_resource/content/1/a840_1_michel_foucault.pdf.
Graf, Chris, Battisti, Wendy P., Bridges, Dan, et al. for the International Society of Medical Publication Professionals. (2009). Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. British Medical Journal, 339:b4330.
Graham, S. Scott., Kessler, Molly M., Kim, Sang-Yeon, et al. (2018). Assessing perspectivalism in patient participation: An evaluation of FDA patient and consumer representative programs. Rhetoric of Health and Medicine, 1(1), 58-89. doi: 10.5744/rhm.2018.1006.
Graham, S.Scott. (2015). The politics of pain medicine: A rhetorical-ontological inquiry. University of Chicago Press.
Holcombe, A. O. (2019, April 18). Contributorship, not authorship: Use CRediT to indicate who did what. https://doi.org/10.3390/publications7030048
International Committee of Medical Journal Editors (ICMJE). (2018). Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. Available at: http://www.icmje.org/icmje-recommendations.pdf
Lynch, John. A. (2009). “Articulating Scientific Practice: Understanding Dean Hamer's “Gay Gene” Study as Overlapping Material, Social and Rhetorical Registers.” Quarterly Journal of Speech. 4(9). http://dx.doi.org/10.1080/00335630903296168.
Stocks Angela, Toroser, Dikran, Simcoe, Donna, DeTora, Lisa. (2018). “Substantial contribution and accountability: best authorship practices for medical writers in biomedical publications.” Current Medical Research and Opinion, 16, 1-6. doi: 10.1080/03007995.2018.1451832.
Wager, Elizabeth, Field, E.A., Grossman, Leni. (2003). Good publication practice for pharmaceutical companies. Current Medical Research and Opinion,19, 149-154.